News
A research team from the CIBER Cancer Division (CIBERONC) at the Salamanca University HealthcareComplex–Salamanca Biomedical Research Institute (IBSAL) and the Cancer Research Center (USAL-CSIC), led
News
The appointment was made official during the members’ meeting held as part of the 24th SOCEPA Congress, which took place in Salamanca from July 7
News
Researchers from IBSAL, INCYL, and USAL are combining cell therapy and gene therapy to protect the brain against inflammation and DNA damage. Bone marrow cells
News
The project led by José Manuel Muñoz Félix, principal investigator at IBSAL and full professor of Biochemistry and Molecular Biology at the University of Salamanca,
Find your news
Discover all the IBSAL news and do not miss any news. All the IBSAL information, management, milestones, advances… at your disposal.
All the news
An advanced therapy succeeds in slowing the loss of neurons in an experimental model of a neurodegenerative disease
Read news "
